ES2062943A1 - Nuevos derivados de la (2-metil-3-piridil) cianometlpiperazinas. - Google Patents

Nuevos derivados de la (2-metil-3-piridil) cianometlpiperazinas.

Info

Publication number
ES2062943A1
ES2062943A1 ES09300591A ES9300591A ES2062943A1 ES 2062943 A1 ES2062943 A1 ES 2062943A1 ES 09300591 A ES09300591 A ES 09300591A ES 9300591 A ES9300591 A ES 9300591A ES 2062943 A1 ES2062943 A1 ES 2062943A1
Authority
ES
Spain
Prior art keywords
cyanomethylpyridine
derivatives
lipoxygenase inhibitors
paf antagonists
nhch
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09300591A
Other languages
English (en)
Other versions
ES2062943B1 (es
Inventor
Elena Carceller
Pere J Jimenez
Carmen Almansa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Noucor Health SA
Original Assignee
J Uriach y Cia SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by J Uriach y Cia SA filed Critical J Uriach y Cia SA
Priority to ES09300591A priority Critical patent/ES2062943B1/es
Priority to CA002118831A priority patent/CA2118831A1/en
Priority to JP6076436A priority patent/JPH072841A/ja
Priority to US08/216,583 priority patent/US5420131A/en
Priority to EP94104612A priority patent/EP0617032A1/en
Publication of ES2062943A1 publication Critical patent/ES2062943A1/es
Application granted granted Critical
Publication of ES2062943B1 publication Critical patent/ES2062943B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

NUEVOS DERIVADOS DE DE LA (2-METIL-3-PIRIDIL)CIANOMETILPIPERAZINA DE FORMULA I, EN DONDE A REPRESENTA UN ENLACE SENCILLO O BIEN LA AGRUPACION -CONHCH(PH)-, -NHCH(PH)-, -CH(PH)NH-, -SOSI2 SCNHCH(PH)-, - NHCONHCH(PH)- O -OCONHCH(PH)-; N ES 0 O 1, Y SUS SALES. LA PRESENTE INVENCION DESCRIBE TAMBIEN PROCEDIMIENTOS PARA SU PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN. DICHOS COMPUESTOS SON ANTAGONISTAS DUALES DEL PAF Y LA 5-LIPOXIGENASA, POR LO TANTO, UTILES EN EL TRATAMIENTO Y/O PREVENCION DE LAS ENFERMEDADES DONDE EL PAF Y/O LA 5-LIPOXIGENASA SE HALLAN IMPLICADOS. FORMULA
ES09300591A 1993-03-23 1993-03-23 Nuevos derivados de la (2-metil-3-piridil) cianometilpiperazinas. Expired - Fee Related ES2062943B1 (es)

Priority Applications (5)

Application Number Priority Date Filing Date Title
ES09300591A ES2062943B1 (es) 1993-03-23 1993-03-23 Nuevos derivados de la (2-metil-3-piridil) cianometilpiperazinas.
CA002118831A CA2118831A1 (en) 1993-03-23 1994-03-11 Derivatives of (2-methyl-3-piridyl) cyanomethylpiperazine
JP6076436A JPH072841A (ja) 1993-03-23 1994-03-23 新規シアノメチルピリジン誘導体
US08/216,583 US5420131A (en) 1993-03-23 1994-03-23 Cyanomethylpyridine derivatives
EP94104612A EP0617032A1 (en) 1993-03-23 1994-03-23 Cyanomethylpyridine derivatives as PAF antagonists and 5-lipoxygenase inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09300591A ES2062943B1 (es) 1993-03-23 1993-03-23 Nuevos derivados de la (2-metil-3-piridil) cianometilpiperazinas.

Publications (2)

Publication Number Publication Date
ES2062943A1 true ES2062943A1 (es) 1994-12-16
ES2062943B1 ES2062943B1 (es) 1995-11-16

Family

ID=8281207

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09300591A Expired - Fee Related ES2062943B1 (es) 1993-03-23 1993-03-23 Nuevos derivados de la (2-metil-3-piridil) cianometilpiperazinas.

Country Status (5)

Country Link
US (1) US5420131A (es)
EP (1) EP0617032A1 (es)
JP (1) JPH072841A (es)
CA (1) CA2118831A1 (es)
ES (1) ES2062943B1 (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962490A (en) 1987-09-25 1999-10-05 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5571821A (en) * 1993-05-20 1996-11-05 Texas Biotechnology Corporation Sulfonamides and derivatives thereof that modulate the activity of endothelin
US5514691A (en) * 1993-05-20 1996-05-07 Immunopharmaceutics, Inc. N-(4-halo-isoxazolyl)-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5591761A (en) * 1993-05-20 1997-01-07 Texas Biotechnology Corporation Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5594021A (en) * 1993-05-20 1997-01-14 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl sulfonamides and derivatives thereof that modulate the activity of endothelin
US5639782A (en) * 1992-03-04 1997-06-17 Center For Innovative Technology Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors
US5463083A (en) * 1992-07-13 1995-10-31 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
PT650485E (pt) 1992-07-13 2001-03-30 Millennium Pharm Inc 2,5-diaril-tetra-hidro-tiofenos -furanos e analogos para o tratamento de desordens inflamatorias e imunitarias
US5434151A (en) * 1992-08-24 1995-07-18 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US6030991A (en) * 1993-05-20 2000-02-29 Texas Biotechnology Corp. Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6613804B2 (en) 1993-05-20 2003-09-02 Encysive Pharmaceuticals, Inc. Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
US6342610B2 (en) 1993-05-20 2002-01-29 Texas Biotechnology Corp. N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5792776A (en) * 1994-06-27 1998-08-11 Cytomed, Inc., Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5750565A (en) * 1995-05-25 1998-05-12 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5703093A (en) * 1995-05-31 1997-12-30 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
FR2721610B1 (fr) * 1994-06-28 1996-08-23 Adir Nouveaux dérivés (thia)cycloalkyl [b] indoles, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
US5891460A (en) * 1995-06-07 1999-04-06 University Of Southern California University Park Campus Method for reducing or preventing post-surgical adhesion formation using ketotifen and analogs thereof
US5977117A (en) * 1996-01-05 1999-11-02 Texas Biotechnology Corporation Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin
US5958905A (en) 1996-03-26 1999-09-28 Texas Biotechnology Corporation Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin
US5804585A (en) 1996-04-15 1998-09-08 Texas Biotechnology Corporation Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin
JP3455233B2 (ja) 1997-04-28 2003-10-14 テキサス・バイオテクノロジー・コーポレイシヨン エンドテリン介在障害治療用のスルホンアミド類
US5783705A (en) * 1997-04-28 1998-07-21 Texas Biotechnology Corporation Process of preparing alkali metal salys of hydrophobic sulfonamides
WO2000077027A2 (en) * 1999-06-14 2000-12-21 Tularik Limited Serine protease inhibitors
TWI250152B (en) 1998-07-21 2006-03-01 Eisai Co Ltd N,N-substituted cyclic amine compounds used as calcium antagonizer
JP2003502314A (ja) 1999-06-14 2003-01-21 イーライ・リリー・アンド・カンパニー 化合物
WO2001034135A2 (en) * 1999-11-11 2001-05-17 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
US6906072B1 (en) * 2000-01-20 2005-06-14 Eisai Co., Ltd. Piperazine compound and pharmaceutical composition containing the compound
US7074934B2 (en) * 2000-06-13 2006-07-11 Tularik Limited Serine protease inhibitors
PL377733A1 (pl) * 2002-11-07 2006-02-06 University Of Pittsburgh Of The Commonwealth System Of Higher Education Leczenie wstrząsu krwotocznego
EP1976841A4 (en) * 2005-12-19 2010-07-28 Neuromed Pharmaceuticals Ltd HETEROCYCLIC AMIDDERIVES AS CALCIUM CHANNEL BLOCKERS
US20090012010A1 (en) * 2007-05-18 2009-01-08 Neuromed Phramaceuticals Ltd. Amino acid derivatives as calcium channel blockers
SG175390A1 (en) 2009-04-29 2011-12-29 Amarin Corp Plc Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
CN113784713A (zh) * 2019-01-11 2021-12-10 纳吉斯制药股份有限公司 白三烯合成抑制剂

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0284359A1 (en) * 1987-03-24 1988-09-28 Takeda Chemical Industries, Ltd. 1,4-Disubstituted piperazine compounds, their production and use
EP0441226A1 (en) * 1990-01-29 1991-08-14 J. URIACH & CIA. S.A. (cyanomethyl)pyridines useful as PAF antagonists
EP0528172A1 (en) * 1991-08-08 1993-02-24 J. URIACH & CIA. S.A. (2-Alkyl-3-pyridyl)methylpiperazine derivatives as PAF antagonists

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57165394A (en) * 1981-04-02 1982-10-12 Ono Pharmaceut Co Ltd Phospholipid derivative, its preparation, and blood platelet activating factor antagonistic agent contraining the same
JPS57169478A (en) * 1981-04-10 1982-10-19 Nippon Chemiphar Co Ltd Piperazine derivative
JPH0240648B2 (ja) * 1981-08-25 1990-09-12 Takeda Chemical Industries Ltd Ketsushobankatsuseiinshokuseizai
JPS6081194A (ja) * 1983-10-11 1985-05-09 Takeda Chem Ind Ltd ケトアルキルリン脂質
JPS60104066A (ja) * 1983-11-10 1985-06-08 Ono Pharmaceut Co Ltd グリセリン誘導体
DK160818C (da) * 1983-12-30 1991-10-07 Hoffmann La Roche N-ring-holdige glycerolderivater, fremgangsmaade til fremstilling deraf, anvendelse deraf til fremstilling af et blodpladeaktiveringsfaktorhaemmende middel samt laegemidler indeholdende en saadan forbindelse
DE3586746T2 (de) * 1984-04-03 1993-03-04 Takeda Chemical Industries Ltd Lipidderivate, ihre produktion und verwendung.
WO1986001507A1 (en) * 1984-08-23 1986-03-13 Sandoz Ag Cyclimmonium salts
JPS6193191A (ja) * 1984-10-10 1986-05-12 サンド・アクチエンゲゼルシヤフト 置換された２‐フラニルまたは５‐オキソ‐２‐フラニル‐アルコキシホスホリルアルキルシクリモニウム塩類
EP0178261A3 (en) * 1984-10-10 1986-12-30 Sandoz Ag Substituted 2-furanyl or 5-oxo-2-furanyl-alkoxy phosphoryl alkyl cyclimmonium salts
US4675390A (en) * 1984-12-03 1987-06-23 Eli Lilly And Company 2-deoxypentose derivatives
GB8504871D0 (en) * 1985-02-26 1985-03-27 Ici Plc Heterocyclic compounds
US4876346A (en) * 1985-05-02 1989-10-24 American Home Products Corporation Quinoline compounds
EP0209239B1 (en) * 1985-07-15 1989-03-01 Takeda Chemical Industries, Ltd. 2-alkanoyloxypropane derivatives, their production and use
EP0210804B1 (en) * 1985-07-26 1989-05-10 Sankyo Company Limited Phosphate ester derivatives, their preparation and their therapeutic use
JP2556849B2 (ja) * 1986-02-13 1996-11-27 三共株式会社 グリセリン誘導体
GB8604000D0 (en) * 1986-02-18 1986-03-26 Roussel Lab Ltd Chemical compounds
KR950002551B1 (en) * 1986-07-04 1995-03-21 Sankyo Co Cyclic ether derivatives, their preparation and use
JP2561478B2 (ja) * 1986-07-22 1996-12-11 武田薬品工業株式会社 グリセリン誘導体
KR960004827B1 (ko) * 1987-01-20 1996-04-16 다이닛뽄 세이야꾸 가부시끼가이샤 헤테로아릴카르복시아미드 유도체, 그의 제조방법 및 그것을 함유하는 의약조성물
GB8701727D0 (en) * 1987-01-27 1987-03-04 Scras Tetrahydrofuran derivatives
GB2205833B (en) * 1987-06-12 1991-03-27 Scras Aminoacylates of glycerol acetal
EP0301751B1 (en) * 1987-07-31 1993-03-10 Takeda Chemical Industries, Ltd. Pyridinium derivatives, their production and use
DE3871705T2 (de) * 1987-10-13 1992-12-17 Uriach & Cia Sa J 2,4-disubstituierte tetrahydrofuranderivate.
ES2005031A6 (es) * 1987-10-13 1989-02-16 Uriach & Cia Sa J Procedimiento para la obtencion de 1,3-dioxolanos 2,4-disustituidos.
US5102881A (en) * 1988-06-27 1992-04-07 Merck Frosst Canada, Inc. Quinoline ether alkanoic acids
ES2013834A6 (es) * 1989-01-30 1990-06-01 Uriach & Cia Sa J Procedimiento para la obtencion de derivados 4-sustituidos de 2-alcoxitetrahidrofurano.
ES2010145A6 (es) * 1989-03-02 1989-10-16 Uriach & Cia Sa J Procedimiento para la obtencion de derivados de la 2-picolilamina.
WO1990012006A1 (en) * 1989-04-07 1990-10-18 Pfizer Inc. Substituted 1-[3-(heteroarylmethoxy)phenyl]alkanols and related compounds in the treatment of asthma, arthritis and related diseases
ES2163399T3 (es) * 1991-03-04 2002-02-01 Univ Virginia Derivados de neolignano como antagonistas receptores del factor de activacion de plaquetas e inhibidores 5-lipooxigenasa.
DE4129742A1 (de) * 1991-09-06 1993-03-11 Bayer Ag Heterocyclisch substituierte chinolylmethoxy-phenylacetamide
ES2068742B1 (es) * 1993-02-11 1995-11-16 Uriach & Cia Sa J Nuevos derivados de piridinio.

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0284359A1 (en) * 1987-03-24 1988-09-28 Takeda Chemical Industries, Ltd. 1,4-Disubstituted piperazine compounds, their production and use
EP0441226A1 (en) * 1990-01-29 1991-08-14 J. URIACH & CIA. S.A. (cyanomethyl)pyridines useful as PAF antagonists
EP0528172A1 (en) * 1991-08-08 1993-02-24 J. URIACH & CIA. S.A. (2-Alkyl-3-pyridyl)methylpiperazine derivatives as PAF antagonists

Also Published As

Publication number Publication date
ES2062943B1 (es) 1995-11-16
JPH072841A (ja) 1995-01-06
CA2118831A1 (en) 1994-09-24
US5420131A (en) 1995-05-30
EP0617032A1 (en) 1994-09-28

Similar Documents

Publication Publication Date Title
ES2062943A1 (es) Nuevos derivados de la (2-metil-3-piridil) cianometlpiperazinas.
ID17851A (id) Persenyawaan heterosiklis, produksi dan pemakaiannya
EA200000096A1 (ru) Производные арилоксиарилсульфониламиногидроксамовой кислоты
MY113732A (en) Arylthio compounds
EP0703902A4 (es)
ES2124668A1 (es) "nuevosl-arilpirazoles con propiedades plaguicidas.
BG102792A (bg) Производни на заместени 4-хидроксифенилалканоилови киселини с агонистична активност към рраr-гама
TW328089B (en) New azolidinediones as antihyperglycemic agents
ATE119774T1 (de) Imidazopyridinderivate und ihre verwendung.
AU1172999A (en) Novel apoptosis inhibitors
EA200100310A1 (ru) Кислородсодержащие гетероциклические соединения
NZ503912A (en) Piperidinylaminomethyl trifluoromethyl cyclic ether compounds and their use as substance P antagonists
CA2159817A1 (en) Pyrimidine Acyclonucleoside Derivatives
ES2057834T3 (es) Compuestos de triazol de utilidad como desactivadores de metales.
WO1999009965A3 (en) Anti-inflammatory agent
ES8707525A1 (es) Un procedimiento para la preparacion de nuevas isoindolinil-alquilpiperazinas
TW324009B (en) Pyrazole condensation ring derivative, its production process and its use as androgen inhibitor
NZ304438A (en) Substituted triazole derivatives and antifungal compositions
BG104309A (en) 8-azabicyclo[3,2,1]octane-3-methanamine derivatives as ligands of d2 and d3 dopamine and 5ht1a and 5ht2 serotonin receptors
ES8304091A1 (es) Procedimiento para preparar derivados de imidazol.
TW262467B (es)
ZA983273B (en) An electrolyte for the electrolytic high-speed deposition of aluminum on continuous products
IL92646A0 (en) Imidazolyl and pyridyl derivatives of phenyl substituted 1,4-dihydropyridines,their preparation and pharmaceutical compositions containing them
ES2061406A1 (es) Nuevos derivados de la 2-(quinolina) con actividad farmacologica.
AU4932590A (en) Cyclic guanidines uses as calcium antagonists

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20040503